APA (7th ed.) Citation

K, Z., S, X., Y, Z., & C, T. (2025). Real-world safety of deucravacitinib: Insights from the Food and Drug Administration Adverse Event Reporting System. International journal of clinical pharmacy, 47(5), 1215. https://doi.org/10.1007/s11096-025-01896-1

Chicago Style (17th ed.) Citation

K, Zhao, Xiao S, Zhao Y, and Tu C. "Real-world Safety of Deucravacitinib: Insights from the Food and Drug Administration Adverse Event Reporting System." International Journal of Clinical Pharmacy 47, no. 5 (2025): 1215. https://doi.org/10.1007/s11096-025-01896-1.

MLA (9th ed.) Citation

K, Zhao, et al. "Real-world Safety of Deucravacitinib: Insights from the Food and Drug Administration Adverse Event Reporting System." International Journal of Clinical Pharmacy, vol. 47, no. 5, 2025, p. 1215, https://doi.org/10.1007/s11096-025-01896-1.